Skip to main content
Clinical Trials/NL-OMON31017
NL-OMON31017
Not Yet Recruiting
Phase 2

Stenting of Haemodialysis Acces Trial - SHARE Trial

W. L. Gore & Associates Inc, U.S.A.0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
outflow-stenosis
Sponsor
W. L. Gore & Associates Inc, U.S.A.
Enrollment
20
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
W. L. Gore & Associates Inc, U.S.A.

Eligibility Criteria

Inclusion Criteria

  • Patient of 18 years of age
  • Patient has a life expectancy of at least 2 years
  • Patient has re\- stenosis within 2 cm from the anastomosis of a loop arterio venous fistula
  • Signed informed consent

Exclusion Criteria

  • Patient unsuitable for administration of contrast agent
  • Dementio or atered mental status that would prohibit giving conscious informed consent
  • Need for adjunctive major surgical procedures within 1 month
  • Other stenosis

Outcomes

Primary Outcomes

Not specified

Similar Trials